{"id":"https://openalex.org/W2808616632","doi":"https://doi.org/10.1007/s12325-018-0727-8","title":"Rapid and Consistent Improvements in Morning PEF in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab","display_name":"Rapid and Consistent Improvements in Morning PEF in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab","alternate_titles":[],"publication_year":2018,"publication_date":"2018-06-15","ids":{"openalex":"https://openalex.org/W2808616632","doi":"https://doi.org/10.1007/s12325-018-0727-8","mag":"2808616632","pmid":"https://pubmed.ncbi.nlm.nih.gov/29949045","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11343775"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-018-0727-8","doi":"https://doi.org/10.1007/s12325-018-0727-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-018-0727-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-018-0727-8.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2808616632"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12325-018-0727-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058416167","display_name":"Hector G. Ortega","orcid":"https://orcid.org/0000-0002-2632-6370","observed_orcids":["https://orcid.org/0000-0002-2632-6370"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hector Ortega","raw_affiliation_strings":["Respiratory US Medical Affairs, GlaxoSmithKline, La Jolla, CA, USA. hectorortega15@hotmail.com","Respiratory US Medical Affairs, GlaxoSmithKline, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory US Medical Affairs, GlaxoSmithKline, La Jolla, CA, USA. hectorortega15@hotmail.com","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Respiratory US Medical Affairs, GlaxoSmithKline, La Jolla, CA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022389916","display_name":"Andrew N Menzies-Gow","orcid":"https://orcid.org/0000-0001-9707-4986","observed_orcids":["https://orcid.org/0000-0001-9707-4986"]},"institutions":[{"id":"https://openalex.org/I4210096640","display_name":"Royal Brompton Hospital","ror":"https://ror.org/00cv4n034","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800036501","https://openalex.org/I4210096640"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Menzies-Gow","raw_affiliation_strings":["Respiratory Medicine, Royal Brompton Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Medicine, Royal Brompton Hospital, London, UK","institution_ids":["https://openalex.org/I4210096640"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091892074","display_name":"Jean\u2010Pierre Llanos","orcid":"https://orcid.org/0000-0002-7785-6881","observed_orcids":["https://orcid.org/0000-0002-7785-6881"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Pierre Llanos","raw_affiliation_strings":["Respiratory US Medical Affairs, GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory US Medical Affairs, GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000455023","display_name":"Mark S. Forshag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Forshag","raw_affiliation_strings":["Respiratory US Medical Affairs, GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory US Medical Affairs, GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018919281","display_name":"Frank C. Albers","orcid":"https://orcid.org/0000-0001-7039-4621","observed_orcids":["https://orcid.org/0000-0001-7039-4621"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frank Albers","raw_affiliation_strings":["Respiratory Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029977828","display_name":"Necdet B. Gunsoy","orcid":"https://orcid.org/0000-0003-1298-2462","observed_orcids":["https://orcid.org/0000-0003-1298-2462"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Necdet Gunsoy","raw_affiliation_strings":["Clinical Statistics, GlaxoSmithKline, Stockley Park, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Statistics, GlaxoSmithKline, Stockley Park, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113812258","display_name":"Eric Bradford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric S. Bradford","raw_affiliation_strings":["Respiratory Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076439834","display_name":"Steven W. Yancey","orcid":"https://orcid.org/0000-0002-9140-3838","observed_orcids":["https://orcid.org/0000-0002-9140-3838"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven W. Yancey","raw_affiliation_strings":["Respiratory Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Therapeutic Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101732168","display_name":"Monica Kraft","orcid":"https://orcid.org/0000-0003-2626-2183","observed_orcids":["https://orcid.org/0000-0003-2626-2183"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monica Kraft","raw_affiliation_strings":["Department of Medicine, University of Arizona, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Arizona, Tucson, AZ, USA","institution_ids":["https://openalex.org/I138006243"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5058416167"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":2.124,"has_fulltext":true,"cited_by_count":20,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.87008511,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"35","issue":"7","first_page":"1059","last_page":"1068"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/mepolizumab","display_name":"mepolizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/eosinophilic-asthma","display_name":"eosinophilic asthma","score":0.8489999771118164},{"id":"https://openalex.org/keywords/peak-expiratory-flow","display_name":"peak expiratory flow","score":0.9160000085830688},{"id":"https://openalex.org/keywords/eosinophil-count","display_name":"eosinophil count","score":0.9160000085830688},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.8399999737739563},{"id":"https://openalex.org/keywords/early-treatment-response","display_name":"early treatment response","score":0.4970000088214874},{"id":"https://openalex.org/keywords/fixed-effects-meta-analysis","display_name":"fixed-effects meta-analysis","score":0.6470000147819519},{"id":"https://openalex.org/keywords/mensa","display_name":"Mensa","score":0.7179999947547913},{"id":"https://openalex.org/keywords/musca","display_name":"Musca","score":0.9599999785423279},{"id":"https://openalex.org/keywords/oral-corticosteroid-dose-reduction","display_name":"oral corticosteroid reduction","score":0.6579999923706055},{"id":"https://openalex.org/keywords/asthma-exacerbations","display_name":"asthma exacerbations","score":0.8420000076293945},{"id":"https://openalex.org/keywords/il-5-inhibition","display_name":"IL-5 inhibition","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.9692403078079224},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8890105485916138},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7180880904197693},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.6738781929016113},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.6232297420501709},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5800270438194275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5788283348083496},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5004019737243652},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4486442506313324},{"id":"https://openalex.org/C19720800","wikidata":"https://www.wikidata.org/wiki/Q7722","display_name":"Morning","level":2,"score":0.4472789764404297},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.370900958776474},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1536070704460144},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004804","descriptor_name":"Eosinophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004804","descriptor_name":"Eosinophils","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010366","descriptor_name":"Peak Expiratory Flow Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012129","descriptor_name":"Respiratory Function Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s12325-018-0727-8","doi":"https://doi.org/10.1007/s12325-018-0727-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-018-0727-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-018-0727-8.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11343775","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11343775/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"},{"id":"pmid:29949045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29949045","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"},{"id":"pmh:oai:spiral.imperial.ac.uk:10044/1/64079","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10044/1/64079","pdf_url":null,"source":{"id":"https://openalex.org/S4306401396","display_name":"Spiral (Imperial College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I47508984","host_organization_name":"Imperial College London","host_organization_lineage":["https://openalex.org/I47508984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"1068","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12325-018-0727-8","doi":"https://doi.org/10.1007/s12325-018-0727-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-018-0727-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-018-0727-8.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320318622","display_name":"Ministerul Cercet\u0103rii, Inov\u0103rii \u015fi Digitaliz\u0103rii","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2808616632.pdf","grobid_xml":"https://content.openalex.org/works/W2808616632.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W387031605","https://openalex.org/W1969074282","https://openalex.org/W1980105210","https://openalex.org/W1988758075","https://openalex.org/W1994585625","https://openalex.org/W2009016013","https://openalex.org/W2039930386","https://openalex.org/W2054606150","https://openalex.org/W2061941095","https://openalex.org/W2062918919","https://openalex.org/W2075699130","https://openalex.org/W2095754126","https://openalex.org/W2098276532","https://openalex.org/W2109215965","https://openalex.org/W2135545303","https://openalex.org/W2136576396","https://openalex.org/W2138355864","https://openalex.org/W2147869572","https://openalex.org/W2155915851","https://openalex.org/W2370552689","https://openalex.org/W2511120040","https://openalex.org/W2513258422","https://openalex.org/W2555500639","https://openalex.org/W2604291894","https://openalex.org/W2787491022"],"related_works":["https://openalex.org/W2783827348","https://openalex.org/W2984426046","https://openalex.org/W3095325017","https://openalex.org/W2987323970","https://openalex.org/W3209657993","https://openalex.org/W4387981449","https://openalex.org/W2370552689","https://openalex.org/W2906657448","https://openalex.org/W2574168594","https://openalex.org/W4412552348"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Previous":[1],"studies":[2,21,70],"showed":[3],"that":[4],"mepolizumab":[5,46,77,126,158,286],"significantly":[6],"reduces":[7],"exacerbations":[8],"and":[9,37,104,139,196,230,242,252,280],"oral":[10],"corticosteroid":[11],"use":[12],"in":[13,82,118,150,156,164,215,255,282,287],"patients":[14,83,288],"with":[15,84,144,285,289],"severe":[16,85,290],"eosinophilic":[17,86,291],"asthma.":[18,87,292],"However,":[19],"early":[20,135,251],"reported":[22],"inconsistent":[23],"effects":[24,110],"on":[25,52],"lung":[26,256],"function.":[27],"This":[28],"study":[29,89,264],"specifically":[30],"assessed":[31],"the":[32,38,122,157,165,172,180,216,263],"onset":[33],"of":[34,40,45,63,75,125,267],"clinical":[35],"effect":[36],"relationship":[39,275],"baseline":[41,277],"blood":[42,177,278],"eosinophil":[43,178],"count":[44],"100":[47,78,127],"mg":[48,79,128],"subcutaneous":[49],"(SC)":[50],"administration":[51],"morning":[53],"peak":[54],"expiratory":[55],"flow":[56],"(AM":[57],"PEF).":[58],"METHODS:":[59],"Post":[60],"hoc":[61],"analysis":[62,248],"data":[64],"from":[65,183],"two":[66],"randomized,":[67],"double-blind,":[68],"placebo-controlled":[69],"(MENSA,":[71],"NCT01691521;":[72],"MUSCA,":[73],"NCT02281318)":[74],"4-weekly":[76],"versus":[80],"placebo":[81,131,166,184],"Individual":[88],"results":[90],"were":[91,105,132],"generated":[92],"using":[93,107,262],"a":[94,108,274],"mixed":[95],"model":[96,99],"repeated":[97],"measures":[98],"controlling":[100],"for":[101,205],"multiple":[102],"covariates":[103],"combined":[106],"fixed":[109],"meta-analysis":[111],"via":[112],"inverse-variance":[113],"weighting.":[114],"RESULTS:":[115],"Significant":[116],"improvements":[117,254,281],"AM":[119,151,260,283],"PEF":[120,152,261,284],"after":[121],"first":[123],"dose":[124],"SC":[129],"vs.":[130],"seen":[133],"as":[134,136],"week":[137],"1":[138],"continued":[140],"to":[141,161,226,232],"improve":[142],"further":[143],"subsequent":[145],"doses.":[146],"The":[147,208],"mean":[148,181],"change":[149],"was":[153,174,185],"26":[154],"L/min":[155,163,187,192,198,241],"group":[159,219],"compared":[160],"4":[162],"group,":[167],"p":[168,202],"<":[169,203,209,227,233],"0.001.":[170],"When":[171],"population":[173],"stratified":[175],"by":[176,259],"thresholds":[179],"difference":[182],"24":[186],"(\u2265":[188,193,199,212],"150":[189,210,225,269],"cells/\u00b5L),":[190,195,201],"27":[191],"300":[194,213,228,231],"34":[197],"500":[200,234],"0.001":[204],"all":[206],"subgroups.":[207],"cells/\u00b5L":[211,214,229,235],"previous":[217],"year)":[218],"increased":[220],"13":[221],"L/min,":[222],"while":[223],"both":[224],"ranges":[236],"demonstrated":[237],"comparable":[238],"changes":[239],"(19":[240],"17":[243],"L/min),":[244],"respectively.":[245],"CONCLUSION:":[246],"Our":[247],"has":[249],"shown":[250],"consistent":[253],"function":[257],"measured":[258],"enrollment":[265],"criterion":[266],"\u2265":[268],"eosinophils/\u00b5L.":[270],"We":[271],"also":[272],"identified":[273],"between":[276],"eosinophils":[279],"FUNDING:":[293],"GlaxoSmithKline":[294],"(study":[295],"ID":[296],"208091).":[297]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2808616632","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-21T00:00:00"}
